Insider · CIK 0001864648
Daigneault Alessandra
Reports to the SEC for 1 company · WILMINGTON, DE
Transactions
14
Companies
1
Filings
2
CIK
0001864648
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc.M Exercise/Conversion | +$56.5K |
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc.M Exercise/Conversion | +$40.4K |
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)C Conversion | −$88.8K |
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)C Conversion | −$63.4K |
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-09-02 | NRXPNRX Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-08-23 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$442K |
| 2021-08-19 | NRXPNRX Pharmaceuticals, Inc.M Exercise/Conversion | +$84.1K |
| 2021-08-19 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)C Conversion | −$132K |
| 2021-08-19 | NRXPNRX Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc.A Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)A Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)A Award | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc. · Employee Stock Option (Right to buy)A Award | — |
Recent filings
- 4Daigneault Alessandra0000950142-21-003504SEC(opens sec.gov)
- 4Daigneault Alessandra0000950142-21-001937SEC(opens sec.gov)
Companies
Address
C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600
WILMINGTON, DE, 19801